Skip to content
value.today

Evolutionary Genomics Inc.

FNAMUnlisted company
$4 Mlast known market cap, Jan 2022 — no current value
Compare
World rank
—
no current market cap
Revenue
—
annual
Net income
—
Employees
—

More about Evolutionary Genomics Inc.

Acquisitions and changes
No longer listed: it is not in the SEC's, Nasdaq Trader's and FINRA's lists of US-traded securities (checked 14 November 2026).

Market cap history

Not enough history yet.

CompanyMarket capP/ENet marginRev. growth
Evolutionary Genomics Inc.🇺🇸$4 M———
Eli Lilly and Company🇺🇸$1.20 T43.4×31.9%+44.7%
Johnson & Johnson🇺🇸$652.5 B40.5×16.2%+6.0%
AbbVie Inc.🇺🇸$514.0 B49.7×15.7%+8.6%
Roche Holding AG🇨🇭$370.3 B29.1×19.0%—
UnitedHealth Group Incorporated🇺🇸$367.7 B23.1×3.5%+11.8%
Merck & Co., Inc.🇺🇸$359.8 B146.7×3.6%+1.3%
Novartis AG🇨🇭$286.8 B20.5×24.7%—
Thermo Fisher Scientific Inc.🇺🇸$253.8 B35.9×14.9%+3.9%

P/E and margins use trailing 12-month results where available; growth is the latest fiscal year.

Questions, comparisons and similar companies#

How current the figures are

Market cap:
Jan 7, 2022 (last known)
Profile updated:
Nov 14, 2026

How each figure is collected: data sources and methodology. Market caps in US dollars unless you switch the currency.

Work at Evolutionary Genomics Inc.? Verify and update this profile — free

Use your work e-mail address (on the company's own domain if possible). Fill in only what is new or missing; a link to where the figures are published (annual report, press release) speeds up the review.

Show Evolutionary Genomics Inc.'s ranking on your website Get the badge
Badge preview

The badge updates itself as the ranking changes.

Something wrong or missing about Evolutionary Genomics Inc.? Suggest a correction